Adjuvant treatment Monoclonal antibody Sarcoma TNM staging system Liquid tumor Carcinoma Pathological stage Leukemia Lymphoma Complete remission Checkpoint inhibitor Benign Active surveillance Recurrence or relapse Palliation Partial remission Cancer Refractory Minimal residual disease Adenocarcinoma PET scan Tumor Definitive treatment Antibody drug conjugate Cellular therapy Chemotherapy Maintenance chemotherapy CTCAE Tyrosine kinase inhibitors (TKIs) ECOG performance status Clinical stage Surgical margin Performance status Grade 3, 4, or 5 Cure Complementary therapy Neoadjuvant treatment Multiple myeloma Adjuvant treatment Monoclonal antibody Sarcoma TNM staging system Liquid tumor Carcinoma Pathological stage Leukemia Lymphoma Complete remission Checkpoint inhibitor Benign Active surveillance Recurrence or relapse Palliation Partial remission Cancer Refractory Minimal residual disease Adenocarcinoma PET scan Tumor Definitive treatment Antibody drug conjugate Cellular therapy Chemotherapy Maintenance chemotherapy CTCAE Tyrosine kinase inhibitors (TKIs) ECOG performance status Clinical stage Surgical margin Performance status Grade 3, 4, or 5 Cure Complementary therapy Neoadjuvant treatment Multiple myeloma
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Adjuvant treatment
Monoclonal antibody
Sarcoma
TNM staging system
Liquid tumor
Carcinoma
Pathological stage
Leukemia
Lymphoma
Complete remission
Checkpoint inhibitor
Benign
Active surveillance
Recurrence or relapse
Palliation
Partial remission
Cancer
Refractory
Minimal residual disease
Adenocarcinoma
PET scan
Tumor
Definitive treatment
Antibody drug conjugate
Cellular therapy
Chemotherapy
Maintenance chemotherapy
CTCAE
Tyrosine kinase inhibitors (TKIs)
ECOG performance status
Clinical stage
Surgical margin
Performance status
Grade 3, 4, or 5
Cure
Complementary therapy
Neoadjuvant treatment
Multiple myeloma